Citation Impact
62 standout
Citing Papers
Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Barbara Pro being referenced
Phase III trial of brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients (pts) with CD30+ mature T-cell lymphomas (MTCL).
2015
Three-Year Survival Results From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Systemic Anaplastic Large Cell Lymphoma
2013
Author Peers
| Author | PFM | Oncology | Dermatology | Neurology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Barbara Pro | 30 | 19 | 12 | 15 | 4 | 39 | |
| Monica Marton-Popovici | 5 | 4 | 4 | 764 | |||
| Lisette van Lieshout | 127 | 2 | 20 | 936 | |||
| P. S. Saneesh Babu | 3 | 28 | 2 | 1 | 11 | 344 | |
| W. G�tze | 14 | 817 | |||||
| M. Kuleva | 2 | 1 | 16 | 424 |
All Works
Loading papers...